| Identification | Back Directory | [Name]
Etoposide phosphate | [CAS]
117091-64-2 | [Synonyms]
Etopofos
ETOPOPHOS
BMY 40481
ETOPOSIDE PHOSPHATE
ETOPOSIDE PHOSPHONATE
Etoposide 4'-Phosphate
ETOPOSIDEPHOSPHATE,ETOPOPHOS
Etoposide phosphate≥ 98% (HPLC)
ETOPOSIDE PHOSPHONATE, ETOPOPHOS
BMY-40481, Etoposide 4'-Dihydrogenphosphate
(5R,5aR,8aR,9S)-5-[3,5-DiMethoxy-4-(phosphonooxy)phenyl]-9-[[4,6-O-(1R)-ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
[5R-[5α,5aβ,8aα,9β(R*)]]-5-[3,5-DiMethoxy-4-(phosphonooxy)phenyl]-9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5-[3,5-dimethoxy-4-(phosphonooxy)phenyl]-9-[[4,6-O-(1R)-ethylidene-b-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-, (5R,5aR,8aR,9S)-
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5-[3,5-dimethoxy-4-(phosphonooxy)phenyl]-9-[[4,6-O-(1R)-ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-, (5R,5aR,8aR,9S)- | [EINECS(EC#)]
630-364-1 | [Molecular Formula]
C29H33O16P | [MDL Number]
MFCD00270859 | [MOL File]
117091-64-2.mol | [Molecular Weight]
668.54 |
| Chemical Properties | Back Directory | [Boiling point ]
907.7±75.0 °C(Predicted) | [density ]
1?+-.0.1 g/cm3(Predicted) | [storage temp. ]
-20°C | [form ]
Solid | [pka]
1.13±0.50(Predicted) | [color ]
White to off-white | [Water Solubility ]
Water: 125 mg/mL (186.97 mM) |
| Hazard Information | Back Directory | [Chemical Properties]
White crystalline powder | [Uses]
As a bioequivalent prodrug of the DNA topoisomerase II inhibitor Etoposide (E933750), Etoposide phosphate can be used in the treatment of a wide variety of hematological malignancies and solid tumors.
| [Definition]
ChEBI: Etoposide phosphate is a furonaphthodioxole. | [Brand name]
Etopophos (Bristol-Myers
Squibb). |
|
|